Health of Frozen Transferred Versus Fresh Transferred Children

March 2, 2020 updated by: Mỹ Đức Hospital

Follow-up of Children Born From Freeze-only Versus Fresh Embryo Transfer: a Follow-up of a Randomized Controlled Trial

In order to give strong recommendation on the efficacy and safety of fresh versus frozen embryo transfer, we conduct this study in order to investigate the physical and mental development of children from fresh versus frozen embryo transfer. Based on our Freeze-only study (Vuong et al., 2018), the women without polycystic ovary syndrome undergoing the first or second IVF were randomly assigned to receive either fresh or frozen embryos on day 3 after oocyte retrieval, which leads to the similarity in characteristics of these two groups. Hence, the result from analysing these offsprings would be preciously valuable.

Study Overview

Detailed Description

Since the first live birth after the transfer of a frozen-thawed embryo reported in 1984, cryopreservation has been considered as an enormous revolution in assisted reproductive technology (ART). It is observed that the trend of ART cycles using frozen embryo transfer is on the increase, which leads to a great deal number of children born from frozen embryos. This is the commencement of 2 embryo transfer strategies, the first one is transferring the fresh embryos, the other is freezing all the embryos and transfer them in the next cycle.

Comparing these two strategies, up till now, there are 4 published randomized control trials (RCTs) indicating different methods for certain groups of patients (Chen et al., 2016; Shi et al., 2018; Vuong et al., 2018; Wei et al., 2019). Regarding the efficacy, the freeze-all strategy outweighs the fresh embryo transfer in women with polycystic ovary syndrome (PCOS). While that efficacy gets a controversy in non-PCOS or ovulatory patients; two groups of authors indicated that these 2 strategies are equally effective, while the other group claims that the better result goes to cycles with frozen embryos. In term of safety, the rate of ovarian hyperstimulation syndrome (OHSS) is the equivalent or lower in the freeze-all group, which implies the important role of embryo-freezing in avoiding maternal risk. The question that whether freezing the embryos exerts effect on offspring is not thoroughly understood. The mostly used parameter in evaluating the safety of children is the perinatal status of infants, not the development of these children.

Searching literature, in 2010, S. Pelkonen published a large cohort study indicating that freezing the embryos do not change the rate of prematurity, low birthweight and being small for gestational age (Pelkonen et al., 2010). Looking further in our freeze-only study, our sub-analysis indicates that the livebirth weight of infants born from frozen embryos is 300 gram heavier than that from fresh embryos (Vuong et al., 2018). Following 4 studies comparing fresh and frozen embryo transfer, children from frozen embryos are similar or higher in term of newborn weight, and there is no study investigate the onward development of childrens born from these two strategies. The only proof on the development of children born from fresh verus frozen embryo is from one study with no randomization which states that children from fresh and frozen embryos share similar academic performance at the age 15-16 (Spangmose et al., 2019). We found no study investigate the impact of different embryo transfer strategies on the growth of children resulting from either fresh or frozen embryos.

In order to give strong recommendation on the efficacy and safety of fresh versus frozen embryo transfer, we conduct this study in order to investigate the physical and mental development of children from fresh versus frozen embryo transfer. Based on our Freeze-only study (Vuong et al., 2018), the women without polycystic ovary syndrome undergoing the first or second IVF were randomly assigned to receive either fresh or frozen embryos on day 3 after oocyte retrieval, which leads to the similarity in characteristics of these two groups. Hence, the result from analysing these offsprings would be preciously valuable.

Study Type

Observational

Enrollment (Actual)

255

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tan Binh
      • Ho Chi Minh City, Tan Binh, Vietnam
        • Mỹ Đức Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 5 years (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Live babies born following the frozen embryo transfer and fresh embryo transfer from our Freeze-only study (NCT02471573)

Description

Inclusion Criteria:

  • Live babies born from the first transfer of both freeze-only and fresh embryo transfer group from our Freeze-only study.
  • Parents agree to participate in the study.

Exclusion Criteria:

  • Babies died after perinatal period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Freeze-only
Children born from freeze-only group and frozen embryo transfer
Ages & Stages Questionnaires®, Third Edition (ASQ®-3) is a developmental screening tool designed for use by early educators and health care professionals. It relies on parents as experts, is easy-to-use, family-friendly and creates the snapshot needed to catch delays and celebrate milestones.
Physical development and General health examination
Developmental Red flags Questionnaires
Fresh
Children born from fresh embryo transfer
Ages & Stages Questionnaires®, Third Edition (ASQ®-3) is a developmental screening tool designed for use by early educators and health care professionals. It relies on parents as experts, is easy-to-use, family-friendly and creates the snapshot needed to catch delays and celebrate milestones.
Physical development and General health examination
Developmental Red flags Questionnaires

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The average total ASQ-3 score
Time Frame: Up to 66 months after birth

ASQ-3 (Ages and Stages Questionaires®) has 5 aspects: Communication, Gross motor, Fine motor, Problem solving and Personal-Social Each aspect has 6 questions, if the answer is Yes, score = 10, Sometimes = 5 and Not yet = 0.

ASQ-3 average = average score of 5 aspects.

Up to 66 months after birth

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of breast-feeding
Time Frame: Up to 24 months after birth
Duration of breast-feeding
Up to 24 months after birth
Infant age at which weaning starts
Time Frame: Up to 24 months after birth
Infant age at which weaning starts
Up to 24 months after birth
Score of Communication
Time Frame: Up to 66 months after birth
6 questions, if the answer is Yes, score = 10, Sometimes = 5 and Not yet = 0. Total score will be used: minimum = 0 and maximum = 60. Each aspects in each stages has alternative threshold
Up to 66 months after birth
Score of Gross motor
Time Frame: Up to 66 months after birth
6 questions, if the answer is Yes, score = 10, Sometimes = 5 and Not yet = 0.
Up to 66 months after birth
Score of Fine motor
Time Frame: Up to 66 months after birth
6 questions, if the answer is Yes, score = 10, Sometimes = 5 and Not yet = 0.
Up to 66 months after birth
Score of Problem solving
Time Frame: Up to 66 months after birth
6 questions, if the answer is Yes, score = 10, Sometimes = 5 and Not yet = 0.
Up to 66 months after birth
Score of Personal-Social
Time Frame: Up to 66 months after birth
6 questions, if the answer is Yes, score = 10, Sometimes = 5 and Not yet = 0.
Up to 66 months after birth
The rate of children who have at least one red flag sign
Time Frame: From 2 to 5.5 years after birth

He or she has at least one red flag sign by age

From 2 to < 3 year-old:

  • Has very unclear speech
  • Doesn't understand simple instruction • Doesn't speak in sentences
  • Doesn't make eye contact
  • Loses skills he/she once had

From 3 to < 4 year-old:

  • Can't jump in place
  • Doesn't play pretend or make-believe • Speaks unclearly
  • Can't retell a favorite story
  • Doesn't use "me" and "you" correctly
  • Loses skills he/she once had

From 4 to < 5.5 year-old:

  • Is easily distracted, has trouble focusing on one activity for more than 5 minutes • Doesn't talk about daily activities or experiences
  • Shows extreme behavior
  • Loses skills he/she once had
From 2 to 5.5 years after birth
Name of diseases that lead to hospital admission
Time Frame: Up to 66 months after birth
Name of diseases that lead to hospital admission
Up to 66 months after birth
Number of hospital admission
Time Frame: Up to 66 months after birth
Number of hospital admission
Up to 66 months after birth
Weight
Time Frame: Through study completion, an average of 1.5 months
Weight on the examination date
Through study completion, an average of 1.5 months
Height
Time Frame: Through study completion, an average of 1.5 months
Height on the examination date
Through study completion, an average of 1.5 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gestational age at delivery
Time Frame: At birth
Gestational age at delivery
At birth
Rate of congenital anomalies
Time Frame: At birth
Any congenital anomalies detected in baby born
At birth
Mode of delivery
Time Frame: At birth
Vaginal birth or C-section
At birth
Birth weight
Time Frame: At birth
Weight of baby born
At birth
Head circumference
Time Frame: At birth
Head circumference after birth
At birth
Rate of Periventricular haemorrhage
Time Frame: Up to 28 days after birth
Periventricular haemorrhage II B or worse, will be diagnosed by repeated neonatal cranial ultrasound by the neonatologist according to the guidelines on neuro-imaging described by de Vries et al.
Up to 28 days after birth
Rate of Necrotizing enterocolitis
Time Frame: Up to 28 days after birth
Necrotizing enterocolitis (NEC) will be diagnosed according to Bell.
Up to 28 days after birth
Rate of Proven sepsis
Time Frame: Up to 28 days after birth
Proven sepsis, will be diagnosed on the combination of clinical signs and positive blood cultures.
Up to 28 days after birth
Rate of Composite of poor perinatal outcomes
Time Frame: Up to 28 days after birth
Composite of poor perinatal outcomes, defined as intraventricular haemorrhage, respiratory distress syndrome, necrotizing enterocolitis or neonatal sepsis.
Up to 28 days after birth
Length of neonatal intensive care unit (NICU) admission
Time Frame: Up to 28 days after birth
Number of admission days to NICU
Up to 28 days after birth
Rate of Respiratory distress syndrome
Time Frame: Up to 28 days after birth
Respiratory distress syndrome (RDS), diagnosed as the presence of tachypnoea >60/minute, sternal recession and expiratory grunting, need for supplemental oxygen, and a radiological picture of diffuse reticulogranular shadowing with an air bronchogram
Up to 28 days after birth
Length circumference
Time Frame: At birth
Head circumference after birth Head circumference after birth Head circumference after birth Length circumference after birth
At birth
The rate of long-term illness and chronic conditions
Time Frame: Up to 66 months after birth
Any long-term illness and chronic condition appears in a child
Up to 66 months after birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2019

Primary Completion (ACTUAL)

November 15, 2019

Study Completion (ACTUAL)

November 20, 2019

Study Registration Dates

First Submitted

September 14, 2019

First Submitted That Met QC Criteria

September 19, 2019

First Posted (ACTUAL)

September 23, 2019

Study Record Updates

Last Update Posted (ACTUAL)

March 3, 2020

Last Update Submitted That Met QC Criteria

March 2, 2020

Last Verified

November 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CS/BVMĐ/19/08

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on Developmental score according to The Ages & Stages Questionnaires®, Third Edition - ASQ®-3

3
Subscribe